Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             56 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Case of Anti–PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema Redman, Jason M.
2019
17 3 p. e549-e552
artikel
2 A Case of Heavily Pretreated Metastatic Germ Cell Tumor With Ongoing Long-term Complete Response After Gemcitabine Treatment Vicier, Cécile
2019
17 3 p. e485-e487
artikel
3 Accuracy of CAPRA-S Score for Predicting Long-Term Biochemical Progression After Radical Prostatectomy Hernández Hernández, Casandra
2019
17 3 p. e645-e649
artikel
4 A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder Kao, Chester
2019
17 3 p. e672-e677
artikel
5 A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer Kim, Simon P.
2019
17 3 p. e472-e481
artikel
6 Angiomyolipoma of the Adrenal Glands Kord Valeshabad, Ali
2019
17 3 p. e553-e555
artikel
7 A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205 Hotte, Sebastien J.
2019
17 3 p. 201-208.e1
artikel
8 Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer Gao, Qin
2019
17 3 p. 183-190
artikel
9 A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma Makboul, Rania
2019
17 3 p. e712-e719
artikel
10 Assessing Outcomes and Prognostic Factors for First-Line Therapy in Elderly Patients With Metastatic Renal Cell Carcinoma: Real-Life Data From a Single United Kingdom Institution Uccello, Mario
2019
17 3 p. e658-e663
artikel
11 Association Between Hospitals’ Risk-Adjusted Emergency Department Visits and Survival and Costs in Kidney Cancer Patients Undergoing Nephrectomy Segel, Joel E.
2019
17 3 p. e650-e657
artikel
12 Cardiovascular and Metabolic Toxicity of Abiraterone in Castration-resistant Prostate Cancer: Post-marketing Experience Tsao, Phoebe A.
2019
17 3 p. e592-e601
artikel
13 Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study Knipper, Sophie
2019
17 3 p. 231-237.e2
artikel
14 Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy Gild, Philipp
2019
17 3 p. e488-e493
artikel
15 Corrigendum 2019
17 3 p. 240
artikel
16 Current Therapies of Wilms Tumors in the Adult: Diagnostic Considerations and Treatment Challenges Bradtke, Marlon
2019
17 3 p. e522-e525
artikel
17 Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer Balakrishnan, Ashwin S.
2019
17 3 p. e461-e471
artikel
18 Editorial Board 2019
17 3 p. A5
artikel
19 Effectiveness of Platinum-Based Chemotherapy in Patients With Metastatic Prostate Cancer: Systematic Review and Meta-analysis Leal, Frederico
2019
17 3 p. e627-e644
artikel
20 Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score–Matched Analysis Chung, Ho Seok
2019
17 3 p. e394-e407
artikel
21 Evaluating the Potential Role of Salvage Vesiculectomy for Prostate Cancer Recurrence Wymer, Kevin M.
2019
17 3 p. e536-e540
artikel
22 Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery Moschini, Marco
2019
17 3 p. e541-e548
artikel
23 Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men Shiota, Masaki
2019
17 3 p. e387-e393
artikel
24 How Are Patients With Prostate Cancer Managing Androgen Deprivation Therapy Side Effects? Wibowo, Erik
2019
17 3 p. e408-e419
artikel
25 Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma Labriola, Matthew K.
2019
17 3 p. e513-e521
artikel
26 Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma Okita, Kazutaka
2019
17 3 p. e440-e446
artikel
27 Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma Ellis, Robert J.
2019
17 3 p. e581-e591
artikel
28 Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer Pak, Sahyun
2019
17 3 p. e420-e428
artikel
29 Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial Bracarda, Sergio
2019
17 3 p. e689-e703
artikel
30 Is Malignant Germ-Cell Tumor Associated With Cowden Syndrome? Rushin, Leah
2019
17 3 p. e429-e432
artikel
31 Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma Ren, Wenbiao
2019
17 3 p. e433-e439
artikel
32 Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of “Recurrence” Bertolo, Riccardo
2019
17 3 p. 209-215.e1
artikel
33 Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes Ged, Yasser
2019
17 3 p. e678-e688
artikel
34 Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression Kammerer-Jacquet, Solène-Florence
2019
17 3 p. 169-176.e1
artikel
35 Microsatellite Instability May Predict Response to Sipuleucel-T in Patients With Prostate Cancer Zhang, Kevin Juan
2019
17 3 p. 238-239
artikel
36 Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors Ornstein, Moshe C.
2019
17 3 p. 177-182
artikel
37 Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis Field, Charles A.
2019
17 3 p. e505-e512
artikel
38 New-Generation Hormone Therapies in Nonmetastatic Castration-Resistant Prostate Cancer: Why, Who, When Roviello, Giandomenico
2019
17 3 p. e534-e535
artikel
39 Patterns of Presentation and Treatment Outcomes of Non–clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia Naher, Sayeda
2019
17 3 p. e565-e569
artikel
40 PD-1/PD-L1 Combinations in Advanced Urothelial Cancer: Rationale and Current Clinical Trials Hsu, Miles M.
2019
17 3 p. e618-e626
artikel
41 Prostate Cancer National Summit’s Call to Action Heath, Elisabeth I.
2019
17 3 p. 161-168
artikel
42 Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma Procopio, Giuseppe
2019
17 3 p. e526-e533
artikel
43 Real-world Experience of Cabozantinib as Second- or Subsequent Line Treatment in Patients With Metastatic Renal Cell Carcinoma: Data From the Polish Managed Access Program Bodnar, Lubomir
2019
17 3 p. e556-e564
artikel
44 Red Cell Distribution Width Predicts Prostate-Specific Antigen Response and Survival of Patients With Castration-Resistant Prostate Cancer Treated With Androgen Receptor Axis–Targeted Agents Fukuokaya, Wataru
2019
17 3 p. 223-230
artikel
45 Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy Taylor, Melissa A.
2019
17 3 p. e494-e504
artikel
46 Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma Adashek, Jacob J.
2019
17 3 p. e454-e460
artikel
47 Salvage Surgery After Percutaneous Ablation of Renal Mass in Solitary Kidney in a Patient With Von Hippel-Lindau Gomella, Patrick T.
2019
17 3 p. e482-e484
artikel
48 Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients Alevizakos, Michail
2019
17 3 p. e447-e453
artikel
49 Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Lyon, Timothy D.
2019
17 3 p. 216-222.e5
artikel
50 Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients Klausner, Guillaume
2019
17 3 p. 191-200
artikel
51 Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma Nazzani, Sebastiano
2019
17 3 p. e602-e611
artikel
52 Synchronous Bilateral RCC Is Associated With Poor Recurrence-Free Survival Compared With Unilateral RCC: A Single-Center Study With Propensity Score Matching Analysis Kim, Jung Kwon
2019
17 3 p. e570-e580
artikel
53 Table of Contents 2019
17 3 p. A7-A15
artikel
54 Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non–Muscle-Invasive Bladder Cancer Xu, Yanjie
2019
17 3 p. e704-e711
artikel
55 Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases Dionisi, Valeria
2019
17 3 p. e612-e617
artikel
56 Who Can Avoid Systematic Biopsy Without Missing Clinically Significant Prostate Cancer in Men Who Undergo Magnetic Resonance Imaging-Targeted Biopsy? Nakanishi, Yasukazu
2019
17 3 p. e664-e671
artikel
                             56 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland